Login to Your Account



Vivus Gains Evamist Approval, $140M Payment From Partner

By Jim Shrine


Tuesday, July 31, 2007
Vivus Inc. won FDA approval of its Evamist product, triggering a $140 million milestone payment from a partnership entered earlier this year. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription